quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 20, 2026

Prometheus Energetics Breaks Ground on New Solid Rocket Motor Manufacturing Campus in Indiana

View original at finance.yahoo.com
Prometheus Energetics Breaks Ground on New Solid Rocket Motor Manufacturing Campus in Indiana BLOOMFIELD, Ind. , Feb. 20, 2026 /PRNewswire/ -- Prometheus Energetics, LLC, a U.S.-based merchant supplier of solid rocket motors (SRMs) and energetics and a joint venture between Kratos Defense & Security Solutions, Inc…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Prometheus is projected to begin SRM production in 2027

    80% confidence
  • Breaking ground on this campus reflects shared commitment with RAFAEL to invest own dollars to rapidly stand up trusted, domestic production capacity that can operate at scale

    80% confidence
  • This campus is foundational to ensuring readiness is more than a promise, it is a certainty

    80% confidence
  • The United States faces a growing gap in solid rocket motor and energetics production, representing a national security vulnerability

    80% confidence
  • Today's groundbreaking represents the moment when a known vulnerability in America's solid rocket motor supply chain begins to be closed

    80% confidence
  • Prometheus was created to operate at production scale, delivering trusted, domestically produced energetics systems to meet urgent and long-term U.S. and allied defense needs

    80% confidence
  • At Kratos, affordability is a technology, utilizing proven leading edge approaches and technology to reduce cost, schedule and risk

    80% confidence
  • The Prometheus campus represents Rafael's approach to localized and resilient production in response to modern defense requirements

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com